Clobazam Suspension
Product Images NDC 72162-2608

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 72162-2608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Clobazam Fig1)

A bar graph showing percent reduction in weekly drop seizure rate across four groups: Placebo (N=57), Low dose (N=53), Medium dose (N=58), and High dose (N=49). The reductions increase from placebo (-12.1%) to low (-41.2%), medium (-49.4%), and high dose (-68.3%) groups, with statistical significance noted (* p<0.05, ** p<0.01).*

FDA Label Image

Figure-10 (Clobazam Fig10)

An instructional black-and-white illustration showing a child receiving oral medication using a syringe. A hand holds the syringe gently toward the child's mouth, demonstrating oral administration of a liquid drug suspension.*

FDA Label Image

Figure-11 (Clobazam Fig11)

Illustration showing a hand twisting the cap of a Clobazam oral suspension bottle. Arrows indicate the direction to turn the cap for opening, demonstrating how to properly unseal the medication bottle.*

FDA Label Image

Figure (Clobazam Fig2)

A bar graph showing the proportion of patients (%) categorized by reduction in weekly drop seizure frequency from baseline (%) across four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High. The x-axis displays seizure reduction intervals (Worse, 0 to <20, 20 to <40, 40 to <60, 60 to <80, 80 to 100), and the y-axis shows the proportion of patients in each category. The Clobazam High group has the largest proportion of patients with 80 to 100% seizure reduction.*

FDA Label Image

Figure-3 (Clobazam Fig3)

Clobazam Oral Suspension 2.5 mg/mL in a dark bottle with a white cap, accompanied by a white bottle adapter and two oral syringes. The box for the suspension is also shown, labeled with Clobazam Oral Suspension 2.5 mg/mL, 120 mL, for oral administration only.*

FDA Label Image

Figure-4 (Clobazam Fig4)

An instructional illustration showing a hand holding a bottle of Clobazam Oral Suspension 2.5 mg/mL, with an arrow and text instructing to shake the bottle well before use.*

FDA Label Image

Figure-5 (Clobazam Fig5)

An instructional illustration showing a hand holding a child-resistant cap positioned above the neck of an open bottle, with an arrow indicating the direction to place or remove the cap.*

FDA Label Image

Figure-6 (Clobazam Fig6)

An instructional diagram of an oral dosing syringe for administering Clobazam suspension. The syringe parts are labeled, including the tip, dosage indicators on the barrel, edge of the plunger, barrel, and plunger, which are used for measuring and delivering the medication accurately.*

FDA Label Image

Figure-7 (Clobazam Fig7)

An instructional illustration demonstrating the use of a dosing syringe to withdraw liquid medication from an open suspension bottle. The syringe is partially inserted into the bottle neck, with an arrow indicating the direction of withdrawal upward from the bottle.*

FDA Label Image

Figure-4 (Clobazam Fig8)

An instructional illustration showing how to use a dosing syringe to measure liquid medication. The syringe is positioned vertically, with measurement markings visible, and an arrow indicates the direction to pull the syringe plunger down to draw liquid.*

FDA Label Image

Figure-9 (Clobazam Fig9)

Illustration showing a dosing syringe inserted into a bottle neck, with measurement markings on the syringe barrel from 0 to 4 mL. An arrow points to the plunger edge with the instruction 'Measure to edge of plunger' to guide accurate dosing.*

FDA Label Image

Chemical Structure (Clobazam Str)

Chemical structure diagram of the active ingredient Clobazam showing its molecular arrangement, including a chlorinated benzodiazepine core with two carbonyl groups and attached methyl and phenyl groups.*

FDA Label Image

Label (Lbl721622608)

Label for Clobazam Oral Suspension 2.5 mg/mL by Bryant Ranch Prepack. The product is an oral suspension in a 120 mL container. The label includes storage instructions to keep at 20° to 25°C and advises shaking well before use. Manufactured by Aurobindo Pharma Limited, the label also mentions the product is dispensed with two 10 mL syringes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.